Evidence map›Paper›PMID 34660502›Full record

ArticleFrontiers in public health2021

"Salus Populi Suprema Lex": Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic.

Evaldo Favi, Francesca Leonardis, Tommaso Maria Manzia, Roberta Angelico, Yousof Alalawi, Carlo Alfieri, Roberto Cacciola

Abstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evaldo FaviDepartment of General Surgery, Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Francesca LeonardisIntensive Care Unit, Department of Surgical Sciences, Università di Tor Vergata, Rome, Italy.
Tommaso Maria ManziaHPB Surgery and Transplantation, Department of Surgical SciencesUniversità di Tor Vergata, Rome, Italy.
Roberta AngelicoHPB Surgery and Transplantation, Department of Surgical SciencesUniversità di Tor Vergata, Rome, Italy.
Yousof AlalawiDepartment of Surgery, Kidney Transplantation, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia.
Carlo AlfieriDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Roberto CacciolaHPB Surgery and Transplantation, Department of Surgical SciencesUniversità di Tor Vergata, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In several countries worldwide, the initial response to coronavirus disease 2019 (COVID-19) has been heavily criticized by general public, media, and healthcare professionals, as well as being an acrimonious topic in the political debate. The present article elaborates on some aspects of the United Kingdom (UK) primary reaction to SARS-CoV-2 pandemic; specifically, from February to July 2020. The fact that the UK showed the highest mortality rate in Western Europe following the first wave of COVID-19 certainly has many contributing causes; each deserves an accurate analysis. We focused on three specific points that have been insofar not fully discussed in the UK and not very well known outside the British border: clinical governance, access to hospital care or intensive care unit, and implementation of non-pharmaceutical interventions. The considerations herein presented on these fundamental matters will likely contribute to a wider and positive discussion on public health, in the context of an unprecedented crisis.

Indexed as

COVID-19PandemicsHumansPublic HealthSARS-CoV-2United Kingdomclinical governancecoronavirusCOVID-19modellingnon-pharmaceutical interventionpandemicpublic healthSARS-CoV-2

Identifiers

PMID34660502
PMCPMC8514989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.